InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,576.98
(
0.07%
)
US TECH 100
19,966.80
(
0.28%
)
Dow Jones
39,291.97
(
-0.13%
)
Brent Oil
84.14
(
-0.66%
)
Bitcoin
58,636.23
(
1.06%
)
Post# of 252545
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

dav1234

Send PM Follow Ignore
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

dav1234

Re: DonShimoda post# 158972

Thursday, 03/28/2013 2:14:57 PM

Thursday, March 28, 2013 2:14:57 PM

Post# of 252545
Ariad Pharmaceuticals (ARIA -0.8%) gets only a tentative nod from Goldman Sachs today, after the company initiated the shares with a Neutral rating, saying the stock is fairly valued at current levels. Goldman notes that since its launching of Iclusig last December, the stock has already appreciated 55%, and trades at a healthy premium to both its cancer peers and the broader S&P 500 index
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up